GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant [RNA-Seq]
RNA-seq (gene expression) · human · 57 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 57 samples: 19 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutantCancer cell · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE272261_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1135968 and SRA study SRP519960. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 57 samples.
How we read this: 19 replicated groups read from 57 sample titles; they account for 57 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8397356 BT690_ABE_rep1 BT690_ABE
- GSM8397357 BT690_ABE_rep2 BT690_ABE
- GSM8397358 BT690_ABE_rep3 BT690_ABE
- GSM8397359 BT690_CDK6deg_rep1 BT690_CDK6deg
- GSM8397360 BT690_CDK6deg_rep2 BT690_CDK6deg
- GSM8397361 BT690_CDK6deg_rep3 BT690_CDK6deg
- GSM8397362 BT690_DMSO_ABE_rep1 BT690_DMSO_ABE
- GSM8397363 BT690_DMSO_ABE_rep2 BT690_DMSO_ABE
- GSM8397364 BT690_DMSO_ABE_rep3 BT690_DMSO_ABE
- GSM8397365 BT690_DMSO_CDK6deg_rep1 BT690_DMSO_CDK6deg
- GSM8397366 BT690_DMSO_CDK6deg_rep2 BT690_DMSO_CDK6deg
- GSM8397367 BT690_DMSO_CDK6deg_rep3 BT690_DMSO_CDK6deg
- GSM8397368 BT690_DMSO_RIBO_rep1 BT690_DMSO_RIBO
- GSM8397369 BT690_DMSO_RIBO_rep2 BT690_DMSO_RIBO
- GSM8397370 BT690_DMSO_RIBO_rep3 BT690_DMSO_RIBO
- GSM8397371 BT690_RIBO_rep1 BT690_RIBO
- GSM8397372 BT690_RIBO_rep2 BT690_RIBO
- GSM8397373 BT690_RIBO_rep3 BT690_RIBO
- GSM8397374 BT690_shRNA1_CDK6_rep1 BT690_shRNA1_CDK6
- GSM8397375 BT690_shRNA1_CDK6_rep2 BT690_shRNA1_CDK6
- GSM8397376 BT690_shRNA1_CDK6_rep3 BT690_shRNA1_CDK6
- GSM8397377 BT690_shRNA2_CDK6_rep1 BT690_shRNA2_CDK6
- GSM8397378 BT690_shRNA2_CDK6_rep2 BT690_shRNA2_CDK6
- GSM8397379 BT690_shRNA2_CDK6_rep3 BT690_shRNA2_CDK6
- GSM8397380 BT690_shRNA_scramble_rep1 BT690_shRNA_scramble
- GSM8397381 BT690_shRNA_scramble_rep2 BT690_shRNA_scramble
- GSM8397382 BT690_shRNA_scramble_rep3 BT690_shRNA_scramble
- GSM8397383 HSJD_CDK6deg_rep1 HSJD_CDK6deg
- GSM8397384 HSJD_CDK6deg_rep2 HSJD_CDK6deg
- GSM8397385 HSJD_CDK6deg_rep3 HSJD_CDK6deg
- GSM8397386 HSJD_DMSO_CDKGdeg_rep1 HSJD_DMSO_CDKGdeg
- GSM8397387 HSJD_DMSO_CDKGdeg_rep2 HSJD_DMSO_CDKGdeg
- GSM8397388 HSJD_DMSO_CDKGdeg_rep3 HSJD_DMSO_CDKGdeg
- GSM8397389 HSJD_GBM_002_ABE_rep1 HSJD_GBM_002_ABE
- GSM8397390 HSJD_GBM_002_ABE_rep2 HSJD_GBM_002_ABE
- GSM8397391 HSJD_GBM_002_ABE_rep3 HSJD_GBM_002_ABE
- GSM8397392 HSJD_GBM_002_DMSO_ABE_rep1 HSJD_GBM_002_DMSO_ABE
- GSM8397393 HSJD_GBM_002_DMSO_ABE_rep2 HSJD_GBM_002_DMSO_ABE
- GSM8397394 HSJD_GBM_002_DMSO_ABE_rep3 HSJD_GBM_002_DMSO_ABE
- GSM8397395 HSJD_GBM_002_DMSO_RIBO_rep1 HSJD_GBM_002_DMSO_RIBO
+ 17 more — browse all 57 samples with per-sample file links →
- GSE272262 GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant [ChIP-Seq] 45 samples shares h3g34-mutant, hemispheric, determines, clinically, actionable, gabaergic, neuronal, lineage
- GSE288991 Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity that Associates with a Clinically Aggressive Subtype of Prostate Cancer 18 samples shares clinically, lineage
- GSE162989 Single-cell/single-nucleus RNA-seq of diffuse hemispheric gliomas, H3G34-mutant. 9 samples shares h3g34-mutant, hemispheric
- GSE131050 Purity Independent Subtyping of Tumors (PurIST), a clinically robust single-sample classifier for tumor subtyping in pancreatic cancer (RNA-Seq) 191 samples shares clinically
- GSE329380 A contamination-adjusted tissue thrombopoietic framework identifies a clinically relevant CAF-myeloid niche in non-small cell lung cancer: a paired transcriptomic and survival study 137 samples shares clinically
- GSE262671 NanoCMSer: A Clinically Applicable Tool for Stratification of Colorectal Cancer Samples [March2024.MATCH] 113 samples shares clinically
- GSE319229 Lipotoxic fingerprints in clinically relevant postoperative pancreatic fistula 72 samples shares clinically
- GSE255002 Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosing 70 samples shares clinically
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.